CVS Health Corporation has shown a positive trend recently, with the current price standing at 71.5. The stock has a weekly forecast of +1.2% and a monthly forecast of +5.6%.
🟢 Barclays initiated coverage on shares of CVS Health, setting an “equal weight” rating and a $78.00 price target.
🟢 Stock analysts at SVB Leerink started coverage on CVS Health with an “outperform” rating.
🔴 Diversified Trust Co reduced its stake in CVS Health by 49.0% during the fourth quarter.
🟢 CVS Health updated its FY24 earnings guidance to at least $8.30 per share.
🟢 Hall Laurie J Trustee grew its stake in CVS Health by 0.2% during the fourth quarter.
🔴 Cornerstone Wealth Management LLC raised its holdings in CVS Health by 3.8% in the fourth quarter.
The recent news surrounding CVS Health Corporation has had a mixed impact on its stock price. The initiation of coverage by Barclays and SVB Leerink with positive ratings has likely contributed to the stock’s positive trend. However, the reduction in stake by Diversified Trust Co may have caused some fluctuations.
The updated earnings guidance provided by CVS Health has been received positively by investors, leading to a boost in confidence in the company’s future performance. The growth in stake by Hall Laurie J Trustee also indicates a positive sentiment towards the stock.
Overall, despite some minor setbacks, the general outlook for CVS Health Corporation appears to be optimistic. Investors may continue to monitor the stock closely for any further developments that could impact its price in the future.
Ready to analyze your own portfolio?
Get the same AI-powered insights for any stock you choose. It's easy!
